Pharmaceuticals in the Environment
Pharmaceutical substances can enter the environment through patient or animal use, manufacturing losses or disposal pathways. Regulatory authorities therefore require applicants to assess and manage any potential environmental risks as part of the marketing authorisation process.
NCET supports clients across the full ERA lifecycle, combining regulatory expertise, toxicology, ecotoxicology and environmental fate assessment to deliver proportionate, defensible and regulator-ready outputs.
